PAMP
ELEV

Polar Asset Management Partners’s Elevation Oncology ELEV Stock Holding History

Polar Asset Management Partners’s Portfolio ELEV Stock Details ELEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-54,700
Closed -$281K – 736
2024
Q1 		$281K Buy
+54,700
New +$177K ﹤0.01% 481
2021
Q3 		– Sell
-125,000
Closed -$1.7M – 1275
2021
Q2 		$1.7M Buy
+125,000
New +$1.54M 0.02% 580

Other funds holding ELEV

LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Polar Asset Management Partners's ELEV Position: Q2 2024 in Review

Polar Asset Management Partners sold out of Elevation Oncology (ELEV) in Q2 2024, closing a stake of 54,700 shares — an estimated $281K sold.

Polar Asset Management Partners first reported a position in ELEV in Q2 2021 and held it in 2 quarters. The position peaked at $1.7M in Q2 2021. 81 funds tracked by Wall St. Rank hold ELEV as of Q2 2024.

  • Polar Asset Management Partners reported no remaining Elevation Oncology position as of Q2 2024 after selling out during the quarter.
  • Polar Asset Management Partners sold 54,700 Elevation Oncology shares in Q2 2024, an estimated $281K.
  • Polar Asset Management Partners first reported a position in Elevation Oncology in Q2 2021 and held it in 2 quarters.
  • Polar Asset Management Partners's Elevation Oncology position peaked at $1.7M in Q2 2021.
  • 81 funds tracked by Wall St. Rank held Elevation Oncology as of Q2 2024.

Based on Polar Asset Management Partners's 13F filing for Q2 2024, filed 14 Aug 2024.